WCLC 2023 - Tuesday Highlights

from Lung Cancer Considered Hosted by IASLC

Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu recap three important sessions from Tuesday, September 12th at the IASLC WCLC 2023: Advocates Unite to Increase Lung Cancer Research Funding An update on the AEGEAN Trial--Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable Long-term Outcomes by Radiation Technique for Locally Advanced Non-Small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

WCLC 2023 - Tuesday Highlights

0:00 40:39

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 40 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on September 12, 2023.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.